Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
GSK plcEli Lilly
Last price
£17.59$1,150.96
Currency
GBP
USD
£71B$1T
15.0738.36
£1.18$29.79
0.290.50
£0.67$6.69
3.77%0.61%
Sector
HealthHealth
Employees
66,84150,000
Ticker
£GSK$LLY
Primary listing
LSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in £GSK or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.